Abstract:Alzheimer’s disease (AD) is a complex neurodegenerative disease characterized by progressive amyloid and tau pathology. Quantifying and classifying AD pathology across the human brain is challenging due to its large size and expertise needed for critical evaluation of the morphological variety in structure types (e.g. diffuse vs dense plaques, neurofibrillary tangles, neuropil threads, etc.). High‐throughput microscopy imaging and artificial intelligence allow for large‐scale, quantitative ‘digital pathology’ surveys. Due to their structural differences, distinct pathological aggregates in microscopy images can be identified and quantified by trained artificial neural networks (Tang et al 2019). However, current approaches do not incorporate anatomical segmentation to map the distribution of AD pathology across whole tissue sections. Understanding where and when AD pathology is distributed across different brain regions is critical to defining cell type susceptibility to neurodegeneration. This project’s goal was to create a combined neural network classification and segmentation quantification approach to generate anatomically‐accurate pathology maps of the human hippocampus and investigate the spatial distribution of distinct types of pathology. Whole slide images of 4G8 and Gallyas stained coronal tissue sections from the USC ADRC Neuropathology Core were imaged using a slide scanning microscope (29 patients with low, intermediate, or high AD stages). 4G8 sections were manually annotated and segmented using the Allen Human Brain Atlas into thirteen layered hippocampal subregions and delineated using Quantitative Imaging Toolkit (QIT). The machine learning toolkit Ilastik was utilized to quantify and classify 4G8 amyloid staining (dense vs diffuse plaques) and Gallyas (neurofibrillary tangles) within each hippocampal subregion and overlaid to segmentation maps. In the hippocampus, we found diffuse amyloid pathology increased more rapidly across progressive AD stages compared to dense amyloid plaques or tau neurofibrillary tangles. The ratio of diffuse/dense labeling was highest in the presubiculum and parasubiculum in high AD patients. Patient APOE4 genotype also significantly increased the fraction of diffuse amyloid labeling in high AD patients. Integrating machine learning quantification and classification approaches with anatomical segmentation maps allows for rapid characterization of AD pathology across hippocampal subregions and provides new insights into AD progression across the brain.

Quantitative Assessment of Hippocampal Tau Pathology in AD and PART

Phosphorylated TDP-43 Staging of Primary Age-Related Tauopathy

Primary Age-Related Tauopathy in Human Subcortical Nuclei.

Primary Age-Related Tauopathy in a Chinese Cohort

Spatial proteomics of hippocampal subfield-specific pathology in Alzheimer's disease and primary age-related tauopathy

Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer's Disease

Pay Attention to Primary Age?related Tauopathy

Regional Analysis of Differently Phosphorylated Tau Proteins in Brains from Patients with Alzheimer’s Disease

Oligomeric, phosphorylated, and truncated tau and spliceosome pathology within the entorhinal-hippocampal connectome across stages of Alzheimer's disease

Correction To: Anatomic Survey of Seeding in Alzheimer's Disease Brains Reveals Unexpected Patterns.

PRIMARY AGE-RELATED TAUOPATHY: BIOLOGICAL DEFINITION AND LONGITUDINAL CLINICAL OUTCOME

Distinct Brain Functional Impairment Patterns Between Suspected Non-Alzheimer Disease Pathophysiology and Alzheimer’s Disease: A Study Combining Static and Dynamic Functional Magnetic Resonance Imaging

Tau as a biomarker of cognitive impairment and neuropsychiatric symptom in Alzheimer's disease

Anatomic survey of seeding in Alzheimer’s disease brains reveals unexpected patterns

Epigenetic signatures of regional tau pathology and cognition in the aging and pathological brain.

Hemispheric Asymmetry and Atypical Lobar Progression of Alzheimer-Type Tauopathy

Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease

Study on tau related disease pattern of Alzheimer′s disease based on 18F-APN-1607 PET imaging

Combined segmentation and classification of Alzheimer’s disease pathology distribution within human hippocampal subregions

Transcriptional Signatures of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer's Disease

TDP-43 Is Associated with Subiculum and Cornu Ammonis 1 Hippocampal Subfield Atrophy in Primary Age-Related Tauopathy